iopromide has been researched along with Nephrogenic Systemic Fibrosis in 2 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pietsch, H | 1 |
Jost, G | 1 |
Frenzel, T | 1 |
Raschke, M | 1 |
Walter, J | 1 |
Schirmer, H | 1 |
Hütter, J | 1 |
Sieber, MA | 1 |
Kim, IY | 1 |
Lee, SB | 1 |
Lee, DW | 1 |
Song, SH | 1 |
Seong, EY | 1 |
Kwak, IS | 1 |
2 other studies available for iopromide and Nephrogenic Systemic Fibrosis
Article | Year |
---|---|
Efficacy and safety of lanthanoids as X-ray contrast agents.
Topics: Animals; Biopsy; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Contrast Media; Cyto | 2011 |
Long-term effect of radiocontrast-enhanced computed tomography on the renal function of chronic kidney disease patients.
Topics: Aged; Contrast Media; Female; Glomerular Filtration Rate; Humans; Iohexol; Kidney; Kidney Failure, C | 2012 |